The Keys to Finding New Treatments
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
Key Questions
- What new preventative and acute treatments are coming soon?
- Why aren’t more people diagnosed with migraine?
- What are some common barriers to getting appropriate care, and how can we overcome them?
Interview Notes
Find more about Peter Goadsby, MD and his work here:
- Migraine Disability Assessment Score (MIDAS)
- Headache Impact Test (HIT)
Peter Goadsby, MD
Professor of Neurology and Headache Specialist
King's College London, UK
Dr. Peter J. Goadsby is one of the world’s leading headache neurologists and researchers, and a professor at King’s College London. Dr. Goadsby is on the board of directors for the American Headache Society, as well as the American Migraine Foundation, in addition to serving on the American Registry Migraine Research (ARMR) Scientific Advisory Board and Executive Committee. Dr. Goadsby is also a trustee for The Migraine Trust. He was one of the first to explore CGRP (calcitonin gene-related peptide), the protein known for causing migraine. This discovery has been instrumental in creating the new class of medications CGRP-R antagonists, including Aimovig, Ajovy, and Emgality.
Unlock full access to the entire 2018 Summit, including:
- 30+ Expert interviews with audio clips and transcripts
- Unlimited streaming and downloads
- Lifetime access with no annual fee
Related Talks for: Day 1 (2018) – Migraine Essentials
Aging with Migraine: Changes and Long Term Effects
Allan Purdy, MD
How Migraine Affects Your Mood: Anxiety & Depression
Dawn Buse, PhD
